1.. Introduction {#s1}
================

Antibiotic resistance of pathogens is a global healthcare problem \[[@RSOS170702C1]\]. Overuse and abuse of antibiotics are the most important driving forces in the development of antibiotic resistance by pathogenic bacteria \[[@RSOS170702C2]\]. More than 100 000 tons of antibiotics are used by culture industries \[[@RSOS170702C3]\]. Industrial aquaculture is the fastest growing industry worldwide, and China is the largest aquaculture producer \[[@RSOS170702C4],[@RSOS170702C5]\]. Thus, there is a growing urgency to search for a new therapeutic strategy for controlling aquatic infectious diseases.

Studies have demonstrated that bacterial biofilm is a potential contributor for the antibiotic resistance of pathogens \[[@RSOS170702C6]\]. The formation of biofilms by bacteria can impart as much as a 1000-fold increase in resistance to antimicrobials \[[@RSOS170702C7]\]. Bacterial biofilms, an extracellular matrix consisting of DNA, proteins and polysaccharides, are constructed by bacterial communities to form complex structures and adhere to living or non-living surfaces \[[@RSOS170702C8]\]. The polymeric matrix of the biofilm can retard the diffusion of antibiotics, making it more difficult for the antibiotics to penetrate the biofilm to eliminate the pathogens \[[@RSOS170702C9]\]. The protective architecture of the bacterial biofilm allows the survival of bacteria in hostile environments \[[@RSOS170702C10]\]. Therefore, the application of approaches for controlling biofilm formation for therapeutic approaches is highly desirable.

In the bacterial physiological process, one of the target regulatory mechanisms is quorum sensing (QS). It modulates (or controls) many phenotypes, such as biofilm formation, antibiotic production and virulence factor expression \[[@RSOS170702C11]\]. Interfering with the QS system may inhibit and eventually disrupt biofilm occurrence, thereby lessening the protection of biofilm in pathogens to deleterious agents, including antibiotics. The QS system and the associated QS inhibitors (QSIs) may, therefore, provide novel approaches for treating bacterial infections \[[@RSOS170702C12],[@RSOS170702C13]\]. In fact, numerous QSIs have been identified in macroalgae, plants, fungi and actinomycetes; the compounds include halogenated furanone C30 and garlic extracts \[[@RSOS170702C13]\]. QSIs inhibit bacterial biofilm formation, rendering bacteria more susceptible to antibiotics \[[@RSOS170702C14]\]. Interestingly, unlike conventional antibiotics, QSIs only aid in the clearance of pathogens by destroying biofilm-mediated protection without influencing their growth or the selective pressures against them \[[@RSOS170702C12]\]. Moreover, QSIs may minimize the production of bacterial virulence factors and reduce the risk of septic shock during infection \[[@RSOS170702C12]\]. Thus, biofilm screening based on QSI seems a prudent and wise strategy to provide new therapies for bacterial infections and for controlling antibiotic resistance.

In the present study, QSI screening was performed to identify bacteria that might produce inhibitors of biofilm formation by typical pathogens such as *Pseudomonas aeruginosa*, *Vibrio harveyi* and *Staphylococcus aureus*. The potential of the inhibitor in attenuating the virulence of *P. aeruginosa* was also evaluated.

2.. Material and methods {#s2}
========================

2.1.. Screening of quorum sensing inhibitor-producing strains {#s2a}
-------------------------------------------------------------

Environmental microorganism samples were collected from a pond located on the campus of the Shenzhen Graduate School of Tsinghua University, Shenzhen, China. To enrich the bacteria with those that have colonizing ability, plastic plates were placed for 2 weeks in the pond and the samples were scraped from each plate and suspended individually in sterile phosphate-buffered saline. Single colonies were obtained by coating 10 µl of serially diluted suspensions on Luria-Bertani (LB) medium (yeast extract 5 g, peptone 10 g and NaCl 10 g in a final volume of 1000 ml of distilled water (pH 7.0), solidified with agar). To identify QSI-producing bacteria, the isolates were subjected to the QSI-screening procedure described below.

Screening the bacteria for QSI production was performed as described previously \[[@RSOS170702C15]\]. Briefly, the candidates were screened using *Chromobacterium violaceum* ATCC12472 as the reporter strain. Bacterial isolates that inhibited purple pigment formation by this reporter strain were considered potential candidates \[[@RSOS170702C16]\]. A second reporter strain, *Agrobacterium tumefaciens* A136 (TraI-lacZ fusion (pCF218) (pCF372), which produces a blue colour in the presence of 5-bromo-4-chloro-indolyl-β-[d]{.smallcaps}- galactopyranoside in response to AHL (acyl homoserine lactone, one kind of QS molecules), was used as the negative control \[[@RSOS170702C17]\]. *Pseudomonas aeruginosa* PAO-1 was used as a positive control. The two reporter strains, the positive control, and *V. harveyi* BB120 were all kindly provided by Dr Thomas Wood (The Pennsylvania State University, USA). Wild-type *S. aureus* was purchased from the China General Microbial Culture Collection (Beijing, China). All strains were cultured at 30°C in autoclaved LB broth medium.

2.2.. Identification of quorum sensing inhibitor-producing bacteria {#s2b}
-------------------------------------------------------------------

The potential QSI strains were grown overnight in LB broth at 30°C, and then a 200 µl aliquot of each culture was transferred into a clean 1.5 ml microfuge tube and centrifuged at 7000*g* for 1 min. The flow-through in the tube was discarded, 100 µl of TE buffer was added, and the sample was mixed gently and then boiled for 10 min. The resulting supernatant contained the DNA crude extract (OD~260~/OD~230~ was more than 1.7, and OD~260~/OD~280~ between 1.8 and 2.0). The 16S rRNA gene, which is approximately 1500 bp, was amplified by polymerase chain reaction using the forward primer 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) and the reverse primer 1492R (5′-GGTTACCTTGTTACGACTT-3′) \[[@RSOS170702C18]\], and sequenced at BGI-Shenzhen (BGI China, Mainland). The sequences obtained were assembled, analysed and manually edited using a CAP3 software package. The resulting sequences were compared against those from the NCBI database (<http://www.ncbi.nlm.nih.gov>) using BLAST analysis. To further know the bacterial biochemical characters, the isolates were also analysed using a physico-chemical identification kit (Lichen Biological, Shanghai, China).

2.3.. Crude extracts of the positive quorum sensing inhibitor strains {#s2c}
---------------------------------------------------------------------

The potential QSI strain cultures were extracted according to a published method \[[@RSOS170702C12]\]. Briefly, the target strain was inoculated into 2 l of LB broth and incubated at 30°C on a rotary shaker for 2 days. The culture was centrifuged at 12 000 r.p.m. for 15 min at 4°C. The supernatant was collected and filtered through a 0.22 μm membrane. The filtrate was extracted twice using an equal volume of ethyl acetate. After extraction, the aqueous fraction was designated the aqueous crude extract, and the organic phase was designated the organic crude extract. The aqueous crude extract was concentrated using poly(ethylene glycol)-20000, and the organic crude extract was concentrated using a Rotavapor RII rotary evaporator (Buchi, Flawil, Switzerland).

2.4.. Biofilm biomass assay {#s2d}
---------------------------

The effects of the QSI-positive strain culture filtrate on the biomass of biofilms produced by *P. aeruginosa* PAO1, *V. harveyi* BB120 and *S. aureus* were determined using the crystal violet (CV) method \[[@RSOS170702C19]\]. Briefly, freshly cultured bacteria were added to 96-well polystyrene plates (100 µl per well) and incubated in M63 medium supplemented with 1 mM MgSO~4~, 0.2% glucose and 0.5% casamino acids \[[@RSOS170702C20]\]. Different volumes of the strain filtrate (0.1%--1.1% v/v) or extracts (1% v/v) were added. The mixtures were incubated at 30°C for 48 h. Planktonic cells and spent medium were removed from each culture. The remaining adherent cells were gently rinsed twice using deionized water. A 100 µl aliquot of CV solution (1% w/v) was added to each well for 30 min at room temperature. The excess dye was discarded, and the plates were washed gently and thoroughly using deionized water. The CV-stained cells were solubilized in dimethylsulfoxide, and the absorbance at 570 nm was determined using a Varioskan Flash enzyme-linked immunosorbent assay reader (Thermo Scientific, Pittsburgh, PA, USA). *P. aeruginosa* PAO1, *V. harveyi* BB120 and *S. aureus* cultures incubated in the absence of the target strain filtrate served as negative controls. The QSI (*Z*)-4-bromo-5-(bromomethylene)-2(5H)-furanone (\#53796; Sigma-Aldrich, St Louis, MO, USA) was used as a positive-control QSI. Experiments were performed with 12 replicates (12 replicate wells in 96-well plates) for each treatment. When absorbance was determined, three readings were recorded for each well. The experiments were repeated three times.

2.5.. Biofilm structure determination {#s2e}
-------------------------------------

*Pseudomonas aeruginosa* PAO1, *V. harveyi* BB120 and *S. aureus* were cultured in M63 medium on a rotary shaker at 30°C with a sterilized coverslip placed in the media as a substrate for biofilm formation. A 1% volume of the target strain culture filtrate or crude aqueous extract was added, and the cultures were incubated for 3 days \[[@RSOS170702C21]\]. The biofilms were observed using scanning confocal laser microscopy (SCLM) with a model FV1000 microscope (Olympus, Tokyo, Japan). The thickness of a biofilm was determined by calculating the base of the biofilm cell cluster at the substratum and the apex of the biofilm cell cluster at the bulk--liquid interface farthest from the substratum.

2.6.. Antibiotic sensitivity {#s2f}
----------------------------

*Pseudomonas aeruginosa* PAO1, *V. harveyi* BB120 and *S. aureus* were each cultured in the presence or absence of the filtrate/crude aqueous extract of cultured QSI strain in M63 medium for 3 days as described in the previous section. SCLM was used to measure the tolerance of these pathogenic bacteria in biofilms to antibiotics following treatment with QSI extracts. The antibiotic sensitivities of the pathogens were tested by adding kanamycin (kanamycin sulfate, a kind of aminoglycoside bactericidal antibiotic, final concentration 100 µg ml^−1^) to these cultures individually. One day later, the biofilm structure in all the experimental groups was determined, as mentioned above, using SCLM. In addition, the bacterial viability was determined using a LIVE/DEAD^®^ BacLight™ Bacterial Viability Kit (L-7012; Molecular Probes, Eugene, OR, USA) according to the Product Introduction and checked by SCLM \[[@RSOS170702C22]\]. This kit uses mixtures of SYTO 9 green fluorescent nucleic acid stain and the red fluorescent nucleic acid stain propidium iodide. These stains differ both in their spectral characteristics and in their ability to penetrate healthy bacterial cells. With an appropriate mixture of the SYTO 9 and propidium iodide stains, bacteria with intact cell membranes (live bacteria) stain fluorescent green, whereas bacteria with damaged membranes (dead bacteria) stain fluorescent red.

2.7.. Growth rate {#s2g}
-----------------

The influence of the filtrate of cultured QSI strain on the planktonic growth rate of *P. aeruginosa* PAO1, *V. harveyi* BB120 and *S. aureus* was determined. The three pathogenic bacteria species were cultured with different quantities of the QSI filtrate at 30°C on a rotary shaker. The absorbance was measured every hour at 600 nm using the enzyme-linked immunosorbent assay reader.

2.8.. Pathogenicity assay {#s2h}
-------------------------

Virulence factors produced by *P. aeruginosa*, such as elastase and siderophores, and hydrolytic ectoenzymes are indicators of pathogenicity \[[@RSOS170702C23]\]. Elastase activity was measured using the elastin Congo red assay, and siderophores were detected using the chrome azurol S assay \[[@RSOS170702C24],[@RSOS170702C25]\]. Ectoenzyme activities were detected using the following fluorogenic substrates (Sigma-Aldrich): [l]{.smallcaps}-leucine-7-amido-4-methylcoumarin hydrochloride for aminopeptidase, 4-methylumbelliferyl (MUF)-β-[d]{.smallcaps}-glucoside for β-glucosidase, MUF-phosphate for alkaline phosphatase and MUF-oleate for lipase \[[@RSOS170702C26]\]. The pathogens cultured in the absence of the QSI filtrate served as negative controls, and furanone served as the positive control.

2.9.. Statistical analysis {#s2i}
--------------------------

All the results were reported as mean ± standard error (s.e.). The statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) for Windows program (version 13.0, SPSS Inc., San Rafael, CA). One-way analysis of variance (one-way ANOVA) with Tukey\'s multiple comparisons was used to compare the differences among different treatments. Differences were considered statistically significant when *p* \< 0.05.

3.. Results {#s3}
===========

3.1.. Screening and identifying quorum sensing inhibitor-producing bacteria {#s3a}
---------------------------------------------------------------------------

Hundreds of culturable bacteria were isolated from the plate. After screening the colonies, five isolates could inhibit QS-regulated purple pigment formation by *C. violaceum* (ATCC12472). These candidate isolates were further analysed using the *A. tumefaciens* A136 reporter strain to eliminate false positives produced by long-chain QS signals such as AHL ([figure 1](#RSOS170702F1){ref-type="fig"}). This reporter strain produces a blue pigment in the presence of the long-chain AHL. Nucleotide sequence analysis revealed that the 16S rRNA genes of the five isolates were identical and shared greater than 99% identity with *Proteus mirabilis* strain NCTC 11938. The sequence was deposited in GenBank with the accession number [NR 043997.1](NR043997.1). The isolates tested positive for gelatin hydrolysis, urease, ornithine decarboxylase, xylopyranose and maltose fermentation, further confirming the identity of the isolates as *P. mirabilis* ([table 1](#RSOS170702TB1){ref-type="table"}). *Proteus mirabilis* was stored at China General Microbiological Culture Collection (CGMCC no. 6426). Figure 1.Screening of quorum-sensing inhibitors. (*a*) Screened by *C. violaceum* ATCC12472. Isolates with inhibition of purple pigment formation (rescue ring) were considered as QSI candidates. (*b*) Screened by *A. tumefaciens* A136. The fading of the blue colour indicated the presence of QSI with no interference of long-chain AHLs. Table 1.Physiological and biochemical characterization of *P. mirabilis*.characteristic*P. mirabilis*phenylalaninase−Simmon\'s citrate−gelatin hydrolysis+ornithine decarboxylase+urease+xylopyranose+maltose+hydrolysis of corn oil−[d]{.smallcaps}-mannitol−salicin−esculin−

3.2.. Inhibition of biofilm formation {#s3b}
-------------------------------------

The effects of filtrates prepared from the culture of *P. mirabilis* on the biomass of biofilms formed in cultures of three bacterial pathogens are shown in [figure 2](#RSOS170702F2){ref-type="fig"} (NC, negative control; FC, filtrate of cultured *P. mirabilis*; F, furanone (20 µg ml^−1^); BC, blank control). The filtrate (0.1--1.1%, v/v) effectively inhibited the production of biofilm biomass by each pathogen in a dose-dependent manner. The highest percentage inhibition of biofilm formation by each culture using a 1.1% concentration of the filtrate was as follows: 58.9%, 41.5% and 41.9% for *P. aeruginosa*, *V. harveyi* and *S. aureus*, respectively. The reference, 20 µg ml^−1^ furanone, was as effective as the 0.7% filtrate but had no effect on the biofilm biomass of *S. aureus*. Figure 2.(*a*) Effect on *P. aeruginosa* PAO1. Samples were diluted 100-fold. (*b*) Effect on *V. harveyi* BB120. Samples were diluted 50-fold. (*c*) Effect on *S. aureus*. Samples were diluted 50-fold. Dilution ratios are for the samples, i.e. dimethylsulfoxide solution in which CV-stained cells were solubilized. The data represent the mean values of 12 replicates (12 wells in 96-well plates), with three readings for each replicate. Significant differences are indicated by asterisks (\*\*\**p* \< 0.001).

The inhibition of biofilm formation by the filtrate was further confirmed using SCLM observation. Pathogens formed biofilms on coverslips in M63 medium with or without the filtrate or a crude extract. After a 3-day incubation, the coverslip was washed and stained with bacterial viability dye. In contrast to the negative control, pathogen biofilms treated with a 1% filtrate of *P. mirabilis* cultures were thinner and less adherent ([figure 3](#RSOS170702F3){ref-type="fig"}). In the presence of the 1% filtrate, the thickness of biofilms formed by *P. aeruginosa*, *V. harveyi* and *S. aureus* decreased from 9 to 5 µm, 10 to 6 µm and 5 to 3 µm, respectively ([figure 3](#RSOS170702F3){ref-type="fig"}, [table 2](#RSOS170702TB2){ref-type="table"}). *Vibrio harveyi* treated with the 1% filtrate did not form biofilms ([figure 3](#RSOS170702F3){ref-type="fig"}). Taken together, these results demonstrate that *P. mirabilis* isolates, selected for their ability to inhibit QS, produced an inhibitor of biofilm formation and caused biofilm disruption. Figure 3.Biofilm structures of the three selected pathogenic bacteria after inhibition by the filtrate of *P. mirabilis*. Cultures of pathogenic bacteria were incubated for 3 days with the 1% (v/v) *P. mirabilis* filtrate. Red and green areas indicate dead and viable bacteria, respectively. Images were taken by SCLM. (*a*) With no filtrate; (*b*) with 1% (v/v) filtrate. *N* = 5, 10 × 100. Table 2.Thickness of biofilms treated with kanamycin and a filtrate prepared from cultures of *P. mirabilis*.strainnegative control1% filtrate of cultured *P. mirabilis*100 µg ml^−1^ kanamycin1% filtrate of cultured *P. mirabilis* and 100 µg ml^−1^ kanamycin*P. aeruginosa*9 µm ± 0.56 µm ± 0.5\*\*\*10 µm ± 15 µm ± 0.5\*\*\**V. harveyi*10 µm ± 26 µm ± 0.5\*\*\*9 µm ± 15 µm ± 0.5\*\*\**S. aureus*5 µm ± 0.53 µm ± 0.5\*\*5 µm ± 0.53 µm ± 0.5\*\*[^1]

3.3.. Antibiotic sensitivity {#s3c}
----------------------------

The sensitivity of pathogens to antibiotics was assessed in the presence or absence of the *P. mirabilis* culture filtrate. Kanamycin alone did cause a decrease in the viability of each of the pathogens in the biofilms ([figure 4](#RSOS170702F4){ref-type="fig"}). However, only the cells on or just below the surface of the biofilms were sensitive to kanamycin. Bacteria located deeper within the biofilms might still survive. When biofilms were treated with both the 1% filtrate and kanamycin, the sensitivity of each pathogen to the antibiotics increased significantly. Most of the cells were killed by 100 µg ml^−1^ kanamycin ([figure 4](#RSOS170702F4){ref-type="fig"}). Figure 4.Effects of kanamycin and the filtrate of *P. mirabilis* on the biofilms formed by pathogenic bacteria. (*a*) Effect of 100 µg ml^−1^ kanamycin only. Biofilms formed by the pathogenic bacteria, after culturing for 3 days with no filtrate of *P. mirabilis* + 1 day 100 µg ml^−1^ kanamycin exposure. (*b*) Combined effects of kanamycin and the filtrate. Biofilms formed by the pathogenic bacteria, after culturing for 3 days with 1% (v/v) filtrate of *P. mirabilis* + 1 day 100 µg ml^−1^ kanamycin exposure. Red, green and yellow/brown areas indicate the dead bacteria, live bacteria, and the combined or overlapping of the dead and live bacteria, respectively. *N* = 5, 10 × 100.

3.4.. Effect of the *P. mirabilis* culture filtrate on the planktonic growth of bacteria {#s3d}
----------------------------------------------------------------------------------------

Growth curves were determined in the presence of 0.1%, 0.5% and 1% concentrations of the *P. mirabilis* culture filtrate. There was no significant difference among the experimental and control groups ([figure 5](#RSOS170702F5){ref-type="fig"}). Figure 5.Influence of the *P. mirabilis* filtrate on bacterial growth. (*a*) *Pseudomonas aeruginosa*; (*b*) *V. harveyi*; (*c*) *S. auerus*. Cultures were incubated for 24 h in LB medium in the absence (circles) or presence of 0.1% (squares), 0.5% (triangles) or 1% (inverted triangles) concentrations of the *P. mirabilis* filtrate. NC, negative control; FC, filtrate of cultured *P. mirabilis*.

3.5.. Analysis of pathogenicity {#s3e}
-------------------------------

The influence of the filtrates prepared from the cultures of *P. mirabilis* on the virulence of *P. aeruginosa* is shown in [figure 6](#RSOS170702F6){ref-type="fig"}. Elastase, siderophore and ectoenzymes were selected to indicate bacterial virulence using standard methods described in Material and methods. Elastase activities, siderophore production and ectoenzyme activities in the *P. aeruginosa* treated by filtrates of *P. mirabilis* culture were inhibited significantly compared with those of the negative control ([figure 6](#RSOS170702F6){ref-type="fig"}*a--f*). The activities of alkaline phosphatase, β-glucosidase, aminopeptidase and lipase in the *P. aeruginosa* were all inhibited by the filtrate of cultured *P. mirabilis*. Figure 6.Attenuation of pathogenicity of *P. aeruginosa* by the filtrate of cultured *P. mirabilis*. (*a*) Elastase activity; (*b*) siderophore production; (*c*) alkaline phosphatase production; (*d*) β-glycosidase production; (*e*) aminopeptidase production; (*f*) lipase production. Cultures of *P. aeruginosa* were incubated in LB medium with or without the filtrate of cultured *P. mirabilis*. A well-known QSI (20 µg ml^−1^ furanone) was used as a positive control. NC, negative control; FC, filtrate of cultured *P. mirabilis*; PC, positive control (20 µg ml^−1^ furanone). \**p* \< 0.05, \*\**p* \< 0.01 and \*\*\**p* \< 0.001.

3.6.. Effects of two crude extracts of the *P. mirabilis* culture filtrate {#s3f}
--------------------------------------------------------------------------

The *P. mirabilis* culture filtrate was extracted using ethyl acetate, and the bioactivity of these extracts on biofilm biomass and virulence factors was determined. The crude aqueous extracts of *P. mirabilis* were stronger inhibitors of biofilm formation by *P. aeruginosa*, *V. harveyi* and *S. aureus* ([table 3](#RSOS170702TB3){ref-type="table"}) as well as the activities of virulence factors (elastase activity, siderophore production and hydrolytic ectoenzyme activity) ([table 4](#RSOS170702TB4){ref-type="table"}) than those of the organic extracts. Table 3.Effect of *P. mirabilis* crude extracts on biofilm formation. AE, aqueous crude extracts of *P. mirabilis*; OE, organic crude extracts of *P. mirabilis*; ± s.d.biofilm biomass (absorbance at 570 nm)crude extracts*P. aeruginosaV. harveyiS. aureus*negative control1.01 ± 0.062.14 ± 0.222.21 ± 0.231% AE0.46 ± 0.09\*\*\*1.23 ± 0.13\*\*\*1.21 ± 0.23\*\*\*1% OE0.73 ± 0.13\*\*\*2.03 ± 0.252.15 ± 0.24[^2] Table 4.Effect of the crude extracts of *P. mirabilis* on virulence factors of *P. aeruginosa*. AE, aqueous crude extracts of *P. mirabilis*; OE, organic crude extracts of *P. mirabilis*; data are listed as mean ± s.e. The errors are from six replicate wells in 96-well plates, with three readings for each well.crude extractselastasesiderophorealkaline phosphataseβ-glucosidaseaminopeptidaselipasenegative control0.904 ± 0.0390.648 ± 0.040838.0 ± 21.5805.4 ± 19.7250.5 ± 16.184.2 ± 13.81% AE0.144 ± 0.007\*\*\*0.332 ± 0.047\*\*777.4 ± 19.0\*\*532.4 ± 16.2\*\*\*181.2 ± 5.1\*\*103.1 ± 8.9\*1% OE0.825 ± 0.006\*\*0.599 ± 0.049813.1 ± 8.8692.1 ± 13.1\*\*\*229.5 ± 13.9121.6 ± 11.3\*\*[^3]

4.. Discussion {#s4}
==============

The QS signalling system senses the density of bacterial populations and plays a pivotal role in bacterial communication and regulation of metabolism \[[@RSOS170702C27],[@RSOS170702C28]\]. The expression of more than 6% of the genes of most infectious bacteria is regulated by the QS system, including genes encoding proteins involved in biofilm development, as well as by exotoxin A, catalase, siderophores and exoenzymes \[[@RSOS170702C29]\]. The disruption of a pathogen\'s QS system might prevent and control a number of bacterial diseases that affect the biotechnology and aquaculture industries \[[@RSOS170702C30]\].

In the present study, we screened for bacteria with QSI activity in freshwater using the reporter strains *C. violaceum* ATCC 12472 and *A. tumefaciens* A136. We succeeded in isolating *P. mirabilis*. The filtrate of the *P. mirabilis* cultures was found to significantly inhibit the biofilm formation of Gram-negative pathogens *P. aeruginosa* and *V. harveyi* and the Gram-positive pathogen *S. aureus* (figures [1](#RSOS170702F1){ref-type="fig"} and [2](#RSOS170702F2){ref-type="fig"}, [table 2](#RSOS170702TB2){ref-type="table"}). These two classes of bacterial pathogens employ the following different QS signalling systems: AHLs in Gram-negative and autoinducing peptides in Gram-positive bacteria \[[@RSOS170702C31]\]. This inhibition activity seems similar to that of halogenated furanone, which is one of the well-known QSIs. Furanone could inhibit biofilm formation and attenuate the virulence of *Escherichia coli* by interfering with its AI-2 QS system \[[@RSOS170702C22]\]. It was also found to disrupt biofilm formation in *Streptococcus* mutants by interfering with *luxS*-dependent QS signalling \[[@RSOS170702C32]\]. However, furanone did not change the biofilm formed by *S. aureus*, which is different from that observed in the filtrate of the *P. mirabilis* cultures ([figure 2](#RSOS170702F2){ref-type="fig"}). These results indicate that the elected biofilm inhibitor in this study may be a non-specific antagonist of the QS signalling system, and have complex inhibition mechanisms. In addition, it is worth noting that previous study demonstrated dispersed cells were more virulent compared with biofilm planktonic cells \[[@RSOS170702C33]\]; hence, in future work, biofilm disruption and bacteria elimination need to be performed simultaneously in order to better understand the biofilm influence mechanisms \[[@RSOS170702C34]\].

To identify the bioactive compounds including QSIs, the filtrate of the culture was extracted with ethyl acetate, and the aqueous and organic phases were analysed for their effects on biofilm formation. Only the aqueous crude extracts suppressed biofilm formation ([table 3](#RSOS170702TB3){ref-type="table"}). Moreover, bioactivity decreased quickly when samples were stored at 4°C (data not shown), indicating that the bioactive compounds produced by *P. mirabilis* might be enzymes, although more experiments need to be conducted to test it. Quorum-quenching enzymes purified from certain bacteria have been shown to inhibit biofilm formation \[[@RSOS170702C12]\]. In the present study, inhibition of the QS or biofilm system by bacterial extracts was observed, although the composition of the compounds responsible for this phenotype is unknown. We speculate there are two possible reasons: (1) multiple chemicals produced by the bacteria cause unique effects at a variety of points in the QS system or (2) these compounds are not directly acting on the AI-1 system but, instead, are interfering with a global regulator of QS such as AI-2 \[[@RSOS170702C35]\]. However, to completely understand these broad-spectrum inhibition effects, further studies are ongoing to investigate the mechanism of action of bioactive compounds in the filtrate of *P. mirabilis* culture.

Because of their complex architecture, biofilms are difficult for antibiotics or other inhibitory agents to penetrate, and therefore they increase the resistance of bacteria to antibiotics \[[@RSOS170702C7]\]. Residual pathogens in a biofilm may gradually adapt to antibiotic pressure and evolve a new resistance mechanism \[[@RSOS170702C13]\]. To explore the potential application of the biofilm inhibitor identified here for treating bacterial infections, we compared its activity to kanamycin and determined whether these agents synergized. The *P. mirabilis* culture filtrate did not inhibit the growth of the bacterial pathogens studied here, although it inhibited their biofilm formation. After culturing the three different pathogens with the *P. mirabilis* culture filtrate, most of the cells remained viable, but the biofilms were thin and not intact ([figure 3](#RSOS170702F3){ref-type="fig"}). We further tested the antibiotic sensitivity of biofilms formed by these pathogens in the presence and absence of the *P. mirabilis* filtrate. At the same concentration of kanamycin, the antibiotic alone killed only bacteria located on the surface of the biofilm, whereas kanamycin applied together with the filtrate killed most of the bacteria residing in the biofilm. The susceptibility of the pathogens to antibiotics was significantly improved after the biofilms were destroyed (figures [3](#RSOS170702F3){ref-type="fig"} and [4](#RSOS170702F4){ref-type="fig"}). These results suggest that the *P. mirabilis* culture filtrate synergized with kanamycin. More research works using other antibiotics from a different class with a different mode of action are warranted to further prove this synergistic activity of the *P. mirabilis* culture filtrate on the sensitivity of pathogens to antibiotics.

To cause infections, pathogens must enter their host and withstand host defence mechanisms \[[@RSOS170702C36]\]. To achieve this goal, bacteria synthesize virulence factors to damage host tissues \[[@RSOS170702C37]\]. The QS system of *P. aeruginosa* not only regulates biofilm formation but also triggers the expression of QS-regulated genes encoding virulence factors \[[@RSOS170702C38]\]. We tested the effects of the filtered *P. mirabilis* culture on the production of elastase, siderophores and several hydrolytic ectoenzymes produced by *P. aeruginosa*. The levels of each were significantly decreased in the presence of filtrates or crude aqueous extracts of *P. mirabilis* ([figure 6](#RSOS170702F6){ref-type="fig"} and [table 4](#RSOS170702TB4){ref-type="table"}).

To summarize, we identified the *P. mirabilis* QSI-producing strain using an environmental screening method. Extracts of *P. mirabilis* were antagonistic to pathogenic bacteria QS and affected QS-regulated phenotypes, including biofilm formation, virulence factor production and antibiotic susceptibility. Interestingly, extracts of *P. mirabilis* did not affect the growth of *P. aeruginosa* PAO1. Our experiments represent a first step in isolating new and more effective inhibitors of biofilm formation that may prove to be important for protecting industrial aquaculture from the devastating effects of bacterial infections. However, the chemical compounds and the active mechanisms of the biological extract are needed for further identification, and these works are ongoing in our laboratory.
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